The companies will work together to identify novel biomarkers of the rare genetic disorder Angelman syndrome.
Baylor College of Medicine, Illumina, Aushon Biosystems, SciGene, Invitrogen
Baylor will use the arrays for studying genomic imprinting and its role in developmental diseases.
Quest plans to develop and sell a diagnostic for prostate cancer based on the biomarker.
An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.
In Science this week: reduction in bee phylogenetic diversity, and more.
The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.
The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.